Better Therapeutics Inc. logo

BTTX

NASDAQ

Better Therapeutics Inc.

SectorHealth CareIndustryBiotechnology: Pharmaceutical PreparationsIPO2021
$0.05+0.01 (+28.53%)
Website
News25/Ratings2

Better Therapeutics, Inc. develops prescription digital therapeutics that delivers behavioral therapy, and creates feedback mechanisms using remotely monitored and patient-generated data. Its products include Nutritional Cognitive Behavioral Therapy (Nutritional CBT), behavioral therapy for patients with type 2 diabetes and other cardiometabolic diseases. It also manufactures therapeutic medicines, such as BT—001, BT—002, BT—003, BT—004, and BT—005 for cardiometabolic diseases. The company was incorporated in 2015 and is based in San Francisco, California.

Latest news

25 items